← All diseases
Brain and nervous system
Progressive supranuclear palsy (PSP)
Would you like to receive a message when new research about Progressive Supranuclear Palsy (PSP) is available? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication you'll find one sentence explaining what was studied — and you'll be notified as soon as there is new research on Progressive Supranuclear Palsy (PSP). View what Premium costs.
Publications and studies (1196)
- Commentary or editorialiAn expert's opinion or commentary, not new research. Experience with a New Index to Differentiate Parkinson's Disease and Progressive Supranuclear Palsy. (2021/09/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Reply to: "Experience with a New Index to Differentiate Parkinson's Disease and Progressive Supranuclear Palsy". (2021/09/01) ♡
- Redeemable "Progressive Supranuclear Palsy" Like Paraneoplastic Presentation in Carcinoma Breast. (2021/09/01) ♡
- Does the Anti-Tau Strategy in Progressive Supranuclear Palsy Need to Be Reconsidered? Yes. (2021/08/31) ♡
- Does the Anti-Tau Strategy in Progressive Supranuclear Palsy Need to Be Reconsidered? No. (2021/08/31) ♡
- Immunopathogenesis and proposed clinical score for identifying Kelch-like protein-11 encephalitis. (2021/08/26) ♡
- Evaluation of [(18)F]PI-2620, a second-generation selective tau tracer, for assessing four-repeat tauopathies. (2021/08/24) ♡
- Comparative morphometric evaluation of the brainstem in neurodegenerative diseases with healthy individuals using magnetic resonance imaging. (2021/08/11) ♡
- Contribution of the astrocytic tau pathology to synapse loss in progressive supranuclear palsy and corticobasal degeneration. (2021/07/01) ♡
- Progressive supranuclear palsy: Neuropathology of patients with a short disease duration due to unexpected death. (2021/06/01) ♡
- Metabolic positron-emission tomography/magnetic resonance imaging in primary progressive aphasia and frontotemporal lobar degeneration subtypes: Reassessment of expected [(18)F]-fluorodeoxyglucose uptake patterns. (2021/05/26) ♡
- Environmental Risk Factors for Progressive Supranuclear Palsy. (2021/05/01) ♡
- Abnormal structural connectivity in progressive supranuclear palsy-Richardson syndrome. (2021/04/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Altered ioflupane single-photon emission computed tomography in anti-IgLON5 disease: A new case mimicking probable progressive supranuclear palsy and review of the literature. (2021/04/01) ♡
- In Vivo Assessment of Neuroinflammation in 4-Repeat Tauopathies. (2021/04/01) ♡
- Is Levodopa Response a Valid Indicator of Parkinson's Disease? (2021/04/01) ♡
- Investigating the 1-year decline in midbrain-to-pons ratio in the differential diagnosis of PSP and IPD. (2021/04/01) ♡
- Eye movements and association with regional brain atrophy in clinical subtypes of progressive supranuclear palsy. (2021/03/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Spinal cord stimulation therapy for gait dysfunction in progressive supranuclear palsy patients. (2021/03/01) ♡
- A New MRI Measure to Early Differentiate Progressive Supranuclear Palsy From De Novo Parkinson's Disease in Clinical Practice: An International Study. (2021/03/01) ♡
- The "hypointense substantia nigra" sign. A novel MRI marker of progressive supranuclear palsy. (2021/02/15) ♡
- Disease course and treatment patterns in progressive supranuclear palsy: A real-world study. (2021/02/15) ♡
- Distinct Vestibular Evoked Myogenic Potentials in Patients With Parkinson Disease and Progressive Supranuclear Palsy. (2021/02/12) ♡
- Enablers to Exercise Participation in Progressive Supranuclear Palsy: Health Professional Perspectives. (2021/02/02) ♡
- Effectiveness of Levodopa in Patients with Multiple System Atrophy and Associated Clinicopathological Features. (2021/02/01) ♡
- Automated Categorization of Parkinsonian Syndromes Using Magnetic Resonance Imaging in a Clinical Setting. (2021/02/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Asymmetric, multifocal musculoskeletal pain preceding the onset of progressive supranuclear palsy: A case report. (2021/02/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. LRRK2 and survival in progressive supranuclear palsy. (2021/02/01) ♡
- Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association study. (2021/02/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. The "zig-zag" sign in progressive supranuclear palsy - The slowness of vertical saccades was the clue. (2021/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Recent developments on PET radiotracers for TSPO and their applications in neuroimaging. (2021/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Past, Present, and Future of Non-invasive Brain Stimulation Approaches to Treat Cognitive Impairment in Neurodegenerative Diseases: Time for a Comprehensive Critical Review. (2021/01/20) ♡
- High-Contrast In Vivo Imaging of Tau Pathologies in Alzheimer's and Non-Alzheimer's Disease Tauopathies. (2021/01/06) ♡
- Atypical parkinsonian syndromes in a North African tertiary referral center. (2021/01/01) ♡
- Diagnostic accuracy of MR planimetry in clinically unclassifiable parkinsonism. (2021/01/01) ♡
- Pedunculopontine Nucleus Deep Brain Stimulation for Parkinsonian Disorders: A Case Series. (2021/01/01) ♡
- Neutrophil-to-lymphocyte ratio (NLR) at boundaries of Progressive Supranuclear Palsy Syndrome (PSPS) and Corticobasal Syndrome (CBS). (2021/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Activity-dependent neuroprotective protein (ADNP)-end-binding protein (EB) interactions regulate microtubule dynamics toward protection against tauopathy. (2021/01/01) ♡
- Shape Profile of Corpus Callosum As a Signature to Phenotype Different Dementia. (2021/01/01) ♡
- Primary Progressive Apraxia of Speech: From Recognition to Diagnosis and Care. (2021/01/01) ♡
- Molecular Processing of Tau Protein in Progressive Supranuclear Palsy: Neuronal and Glial Degeneration. (2021/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Current Status and Challenges of Stem Cell Treatment for Alzheimer's Disease. (2021/01/01) ♡
- Neuroimaging in Parkinson's Disease: necessity or exaggeration? (2021/01/01) ♡
- Neuroimaging correlates of gait abnormalities in progressive supranuclear palsy. (2021/01/01) ♡
- Corticospinal tract abnormalities and ventricular dilatation: A transdiagnostic comparative tractography study. (2021/01/01) ♡
- Cerebrospinal Fluid Levels of 5-Hydroxyindoleacetic Acid in Parkinson's Disease and Atypical Parkinsonian Syndromes. (2021/01/01) ♡
- NEUROPSYCHOLOGICAL PRINCIPLES OF COGNITIVE AND COMMUNICATIVE ACTIVITIES DIAGNOSIS IN ADULTS WITH EXTRAPYRAMIDAL SYSTEM DISORDERS. (2021/01/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Optimization of Morphomer-based Alpha-synuclein PET Tracers (2021-10-05) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Study of NBMI Treatment in Patients With Atypical Parkinsons (PSP or MSA) (2021-09-23) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Neurodegenerative Diseases Registry (2021-07-28) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.